Towards precision medicine in COPD: bioradiomic SPECT-CT quantification of active lung inflammation

Welham, Benjamin, Bennett, Michael, Ostridge, Kristoffer, Guy, Matthew, Zvavamwe, Clint, Sundram, Francis and Wilkinson, Tom (2023) Towards precision medicine in COPD: bioradiomic SPECT-CT quantification of active lung inflammation. European Respiratory Journal, 62 (Suppl. 67), [OA4856]. (doi:10.1183/13993003.congress-2023.OA4856).

Abstract

Introduction: multiple inflammatory endotypes exist as targets for therapy in COPD but novel precision medicine approaches are needed to define these. We aim to develop non-invasive imaging methods to quantify specific inflammatory cytokines in the lung as potential targets for therapy.

Methods: using SPECT-CT, we developed techniques to quantify cytokine activity. Five patients with COPD and 5 healthy volunteers were recruited and gave informed consent. They underwent SPECT-CT of the lungs at 6 (+/- 1) and 24 (+/- 4) hours after infusion of 99mTc-anti-TNF-α to quantify TNF-α activity in the lungs. Quantification (figure 1) was normalised to aortic arch signal to account for biological clearance.

Results: isotope signals were quantified at 6 and 24 hours. Median normalised lung SPECT counts (CN) were higher in the healthy group at both time points. However, the increase in CN at 24 hours calculated as a percentage of the 6-hour scan (a measure of tissue bound signal) was higher in the COPD group at 64.88% +/- (SD) 31.04 compared with 35.38% +/- 34.33 in the healthy group - a significant change in the COPD group (p=0.029, paired t-test) but not the healthy.

Conclusions: this proof-of-concept study provides early evidence that molecular imaging of inflammatory cytokines is possible in the lungs of patients with COPD.

This record has no associated files available for download.

Contributors

Author: Matthew Guy

Download statistics